Search details
1.
Effectiveness and safety of empagliflozin: final results from the EMPRISE study.
Diabetologia
; 2024 Mar 21.
Article
in English
| MEDLINE | ID: mdl-38509341
2.
Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study.
Cardiovasc Diabetol
; 23(1): 57, 2024 02 08.
Article
in English
| MEDLINE | ID: mdl-38331813
3.
Hydroxychloroquine lowers Alzheimer's disease and related dementias risk and rescues molecular phenotypes related to Alzheimer's disease.
Mol Psychiatry
; 28(3): 1312-1326, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36577843
4.
Emulation of randomized trials of direct oral anticoagulants with claims data and implications for new Factor XI inhibitors.
Pharmacoepidemiol Drug Saf
; 33(5): e5813, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38720425
5.
Stratified analysis in comparative effectiveness studies that emulate randomized trials.
Pharmacoepidemiol Drug Saf
; 33(1): e5716, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37876341
6.
Validation of alopecia coding in US claims data among women of childbearing age.
Pharmacoepidemiol Drug Saf
; 33(4): e5782, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38566351
7.
Sodium-glucose cotransporter 2 inhibitors vs. sitagliptin in heart failure and type 2 diabetes: an observational cohort study.
Eur Heart J
; 44(24): 2216-2230, 2023 06 25.
Article
in English
| MEDLINE | ID: mdl-37259575
8.
Use patterns of systemic immunomodulators in the United States before and after dupilumab approval in adults with atopic dermatitis.
Pharmacoepidemiol Drug Saf
; 32(5): 567-576, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36527432
9.
Effectiveness research in oncology with electronic health record data: A retrospective cohort study emulating the PALOMA-2 trial.
Pharmacoepidemiol Drug Saf
; 32(4): 426-434, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36345809
10.
High-dimensional propensity scores for empirical covariate selection in secondary database studies: Planning, implementation, and reporting.
Pharmacoepidemiol Drug Saf
; 32(2): 93-106, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36349471
11.
HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force.
Pharmacoepidemiol Drug Saf
; 32(1): 44-55, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36215113
12.
Longitudinal utilization of systemic immunomodulators before and after dupilumab approval in children with atopic dermatitis.
Pediatr Dermatol
; 40(1): 132-134, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36403606
13.
Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin : A Cohort Study.
Ann Intern Med
; 175(7): 927-937, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35605236
14.
Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses: Results of 32 Clinical Trials.
JAMA
; 329(16): 1376-1385, 2023 04 25.
Article
in English
| MEDLINE | ID: mdl-37097356
15.
Decreased risk of treatment failure with vedolizumab and thiopurines combined compared with vedolizumab monotherapy in Crohn's disease.
Gut
; 71(9): 1781-1789, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35387877
16.
Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies: First Results From the RCT DUPLICATE Initiative.
Circulation
; 143(10): 1002-1013, 2021 03 09.
Article
in English
| MEDLINE | ID: mdl-33327727
17.
Glucagon-Like Peptide 1 Receptor Agonists and Risk of Anaphylactic Reaction Among Patients With Type 2 Diabetes: A Multisite Population-Based Cohort Study.
Am J Epidemiol
; 191(8): 1352-1367, 2022 07 23.
Article
in English
| MEDLINE | ID: mdl-35136902
18.
Psychosis with Methylphenidate or Amphetamine in Patients with ADHD.
N Engl J Med
; 380(12): 1128-1138, 2019 03 21.
Article
in English
| MEDLINE | ID: mdl-30893533
19.
Glucagon-Like Peptide-1 Receptor Agonists and Hepatic Decompensation Events in Patients With Cirrhosis and Diabetes.
Clin Gastroenterol Hepatol
; 20(6): 1382-1393.e19, 2022 06.
Article
in English
| MEDLINE | ID: mdl-34256144
20.
Risk of Serious Infections With Vedolizumab Versus Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease.
Clin Gastroenterol Hepatol
; 20(2): 314-324.e16, 2022 02.
Article
in English
| MEDLINE | ID: mdl-33387667